Seven patients with CD25-low ALK+ ALCL had known status of stem cell transplantation (SCT) and three (43%) of them received SCT: one autologous followed by allogeneic, and two allogeneic. The gene discussed is IL2RA; the disease is anaplastic large cell lymphoma.